Cullen Frost Bankers Inc. Sells 137,543 Shares of Agilent Technologies Inc (NYSE:A)

Cullen Frost Bankers Inc. trimmed its position in Agilent Technologies Inc (NYSE:A) by 83.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,146 shares of the medical research company’s stock after selling 137,543 shares during the period. Cullen Frost Bankers Inc.’s holdings in Agilent Technologies were worth $2,081,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Edgestream Partners L.P. bought a new stake in shares of Agilent Technologies in the 2nd quarter worth approximately $2,616,000. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its holdings in Agilent Technologies by 81.0% during the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 157,403 shares of the medical research company’s stock valued at $11,753,000 after acquiring an additional 70,426 shares during the period. Skandinaviska Enskilda Banken AB publ raised its holdings in Agilent Technologies by 2.6% during the 2nd quarter. Skandinaviska Enskilda Banken AB publ now owns 66,135 shares of the medical research company’s stock valued at $4,938,000 after acquiring an additional 1,654 shares during the period. HighTower Advisors LLC raised its holdings in Agilent Technologies by 1,183.0% during the 2nd quarter. HighTower Advisors LLC now owns 122,800 shares of the medical research company’s stock valued at $9,132,000 after acquiring an additional 113,229 shares during the period. Finally, Prentiss Smith & Co. Inc. raised its holdings in Agilent Technologies by 484.9% during the 2nd quarter. Prentiss Smith & Co. Inc. now owns 58,428 shares of the medical research company’s stock valued at $4,363,000 after acquiring an additional 48,438 shares during the period.

In other news, Director Heidi Fields sold 4,000 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $70.96, for a total transaction of $283,840.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Michael R. Mcmullen sold 24,635 shares of the stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $77.50, for a total transaction of $1,909,212.50. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 32,635 shares of company stock valued at $2,507,293.

A number of equities research analysts have issued reports on A shares. Bank of America cut shares of Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 target price on the stock. in a report on Tuesday, July 16th. Piper Jaffray Companies boosted their target price on shares of Agilent Technologies from $83.00 to $86.00 and gave the company an “overweight” rating in a report on Thursday, August 15th. UBS Group cut shares of Agilent Technologies from a “buy” rating to a “neutral” rating and set a $82.00 target price on the stock. in a report on Friday, October 18th. Barclays lowered their target price on shares of Agilent Technologies from $78.00 to $76.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 9th. Finally, Robert W. Baird reissued an “outperform” rating and set a $82.00 target price (up previously from $79.00) on shares of Agilent Technologies in a report on Thursday, August 15th. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $84.00.

Shares of Agilent Technologies stock traded up $0.27 during trading on Friday, hitting $76.18. The stock had a trading volume of 21,354 shares, compared to its average volume of 1,400,664. The firm has a market cap of $23.38 billion, a price-to-earnings ratio of 27.31, a P/E/G ratio of 1.88 and a beta of 1.42. Agilent Technologies Inc has a 12 month low of $62.00 and a 12 month high of $82.27. The business’s 50-day moving average is $75.74 and its 200 day moving average is $72.83. The company has a current ratio of 2.13, a quick ratio of 1.72 and a debt-to-equity ratio of 0.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 14th. The medical research company reported $0.76 earnings per share for the quarter, topping the consensus estimate of $0.72 by $0.04. The firm had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.24 billion. Agilent Technologies had a net margin of 21.06% and a return on equity of 20.00%. The business’s quarterly revenue was up 5.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.67 earnings per share. As a group, equities analysts expect that Agilent Technologies Inc will post 3.08 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st were given a dividend of $0.164 per share. The ex-dividend date was Monday, September 30th. This represents a $0.66 annualized dividend and a yield of 0.86%. Agilent Technologies’s payout ratio is 23.66%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Read More: Why is the conference call important?

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.